InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Optiscan Imaging Limited (ASX: OIL) - Announcements

Current share price for OIL : $0.165 0.005 (3.13%)+

ASX company news and announcements for Optiscan Imaging Limited (OIL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Optiscan Imaging Limited (OIL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Optiscan Imaging Limited (OIL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Optiscan Imaging Limited (OIL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$173 Proposed issue of securities - OIL 27 Aug 2025 11:19AM $0.080 $0.165 risen by 106.25%
$173 Optiscan Launches Entitlement Offer to Raise $17.75m 27 Aug 2025 11:18AM $0.080 $0.165 risen by 106.25%
$173 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2025 3:23PM $0.105 $0.165 risen by 57.14%
$173 Optiscan Initiates Breast Cancer Study in Melbourne 30 Jun 2025 1:25PM $0.100 $0.165 risen by 65%
$173 Optiscan Signs Agreement with Long Grove Pharmaceuticals 23 Jun 2025 8:41AM $0.110 $0.165 risen by 50%
$173 Optiscan Reveals InSpecta Device for Veterinary Medicine 10 Jun 2025 8:38AM $0.115 $0.165 risen by 43.48%
$173 Notification of cessation of securities - OIL 29 May 2025 4:39PM $0.150 $0.165 risen by 10%
$173 Optiscan Completes Cloud-based Telepathology Software MVP 27 May 2025 8:36AM $0.110 $0.165 risen by 50%
$173 Robotic Surgery Collaboration with Mayo Clinic Progresses 13 May 2025 9:35AM $0.110 $0.165 risen by 50%
$173 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 9:10AM $0.135 $0.165 risen by 22.22%
$173 Optiscan Site Tour - Analyst Presentation 10 Apr 2025 9:03AM $0.120 $0.165 risen by 37.50%
$173 Optiscan to Showcase Imaging Tech at Site Tour 9 Apr 2025 1:49PM $0.125 $0.165 risen by 32%
$173 Optiscan Announces New CFO & Other Executive Appointments 31 Mar 2025 9:18AM $0.135 $0.165 risen by 22.22%
$173 Optiscan TSN ASX Gems Conference Presentation 28 Mar 2025 8:36AM $0.138 $0.165 risen by 20%
$173 Optiscan to present at TSN ASX Gems Conference 28 Mar 2025 8:23AM $0.138 $0.165 risen by 20%
$173 Change of Director's Interest Notice 21 Mar 2025 4:08PM $0.120 $0.165 risen by 37.50%
$173 Change of Director's Interest Notice 18 Mar 2025 5:07PM $0.128 $0.165 risen by 29.41%
$173 Change in substantial holding 13 Mar 2025 5:29PM $0.135 $0.165 risen by 22.22%
$173 Change of Director's Interest Notice 10 Mar 2025 5:15PM $0.125 $0.165 risen by 32%
$173 Notification of cessation of securities - OIL 10 Mar 2025 5:14PM $0.125 $0.165 risen by 32%
$173 Half Year Results 27 Feb 2025 12:22PM $0.155 $0.165 risen by 6.45%
$173 Half-year Report - 31 December 2024 27 Feb 2025 12:20PM $0.155 $0.165 risen by 6.45%
$173 Appendix 4D 27 Feb 2025 12:18PM $0.155 $0.165 risen by 6.45%
$173 Optiscan Reveals InForm Imaging Device for Pathology 19 Feb 2025 9:08AM $0.155 $0.165 risen by 6.45%
$173 Change of Company Secretary 4 Feb 2025 8:20AM $0.165 $0.165 fallen by 0%

51 - 75 of 632 results

Page 3 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.